ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novasep, Exelixis Ink ADC Manufacturing Agreement
July 07, 2021Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate. -
Exelixis Announces U.S. FDA Accepts Investigational New Drug Application for XB002 in Patients with Advanced Solid Tumors
April 07, 2021Exelixis, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to evaluate the safety, tolerability, pharmacokinetics and preliminary antitumor activity of XB002 in patients with ...
Pharma Sources Insight January 2025
